Free Newsletter
Vaccine makers to produce record amount of flu jab
The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140 million doses for the last flu season, most of which were useless against the strains that were actually in circulation. Each year some 200,000 people in the U.S. are hospitalized for the flu, and 36,000 people die from it.
- read the report from Newsday
Related Articles:
Flu jab missing the mark in seasonal campaign
Vaccines not useful for seasonal flu
Universal flu vaccine shows early promise
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment